1. Aberg, M, Nilsson, l.M. and Vilhardt, H. (1979) The release of fibrinolytic activator and factor VIII after injection of DDAVP’, in J.F. Davison, V. Cepelak, M.M. Samama and P.C. Desnoyers (eds.) Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 4, Raven Press, New York, pp. 92–7
2. Alkjaersig, N., Fletcher, A.P. and Burstein, R. (1975) ‘Association between oral contraceptive use and thromboembolism: A new approach to its investigation based on plasma fibrinogen chromatography’, American Journal of Obstetrics and Gynecology, 122, 199–211
3. Ambrus, J.L., Nieswander, K.R., Courey, N.G., Wamsteker, E.F. and Mink, LB. (1969) ‘Progestational agents and blood coagulation. II’, American Journal of Obstetrics and Gynecology, 103, 994–1001
4. Amris, C.J. and Starup, J. (1967) ‘The coagulation mechanism in oral contraception’, Acta Obstetrica et Gynecologica Scandinavia, 46, 78–91
5. Amundson, B.A. and Pilgeram, L.O. (1964) ‘Observations on a relationship between steroid metabolism and the concentration of plasma fibrinogen’, Thrombosis et Diathesis Haemorrhagica, 10, 400–5